During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Bristol Myers Squibb said it has received positive results for its latest lymphoma treatment trials, the fifth type of cancer the drug has been shown to treat.

Panel B shows that the ... unexplained clinical symptoms that are consistent with T-cell infiltration, including diarrhea. We report a secondary T-cell lymphoma of the GI tract that has ...

For instance, B-cell markers (CD20 and CD79a), T-cell markers (CD3 and CD5), and other markers like CD23, bcl-2, CD10, cyclinD1, CD15, CD30, ALK-1, CD138 may be used in various blood cancers or ...

But what does it mean to have a flu A or flu B season? Do these types of flu have different symptoms? And does one cause more severe illness than the other? Experts have been studying influenza ...